Comparative usability study of the dulaglutide single-use pen versus the insulin degludec FlexTouch® among self-injection-naïve patients with type 2 diabetes mellitus in Japan
Author:
Affiliation:
1. Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, Niigata city, Niigata, Japan;
2. Eli Lilly Japan, K.K., Chuo-Ku, Kobe, Japan
Publisher
Informa UK Limited
Subject
General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/03007995.2018.1448260
Reference34 articles.
1. Japan Diabetes Society [Internet]. Treatment guide for diabetes, 2014–2015. 2015. Tokyo, Japan. Available online at: www.jds.or.jp/modules/en/index.php?content_id = 1 access December 1, 2017
2. Trulicity Ateos Eli Lilly Japan K.K. Ver 4. Revised March 2017. Kobe, Japan. Available online at: www.info.pmda.go.jp/downfiles/ph/PDF/530471_2499416G1029_1_10.pdf. Japanese accessed December 1, 2017
3. Safe and Effective Use of the Once Weekly Dulaglutide Single-Dose Pen in Injection-Naïve Patients With Type 2 Diabetes
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Discrete Choice Experiment to Understand Japanese Patients’ and Physicians’ Preferences for Preventive Treatments for Migraine;Neurology and Therapy;2023-02-27
2. Patient Perceptions of and Preferences Between Characteristics of Injectable Diabetes Treatments;Diabetes Therapy;2021-07-23
3. Evaluating the usability and safety of the semaglutide single‐dose pen‐injectors through summative (human factors) usability testing;Journal of Diabetes Investigation;2020-11-18
4. The Unmet Medical Needs of Current Injectable Antidiabetic Therapies in China: Patient and Health Care Professional Perspectives;Clinical Therapeutics;2020-08
5. Comparative study of dulaglutide single-use pen Ateos versus insulin degludec FlexTouch on learning and mock administration time in Japanese patients with type 2 diabetes mellitus – a post-hoc analysis;Current Medical Research and Opinion;2020-03-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3